Teradata stock highlights a 520% AI engagement gain

Published on 10/08/2026 at 02:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Teradata's Q2 revenue reached USD 410 million against USD 396.13 million consensus on August 4, 2026. Full-year adjusted EPS guidance is USD 2.65-2.73.

TDC, US88076W1036, Illustration mit AI erstellt.

Teradata stock (ISIN US88076W1036) was last at USD 29.16 on the NYSE on October 7, 2026 at 4:00 p.m. ET, down 1.55 percent from the prior close. The company highlighted a healthcare AI engagement that delivered a 520 percent increase in patient engagement, according to FT on October 7, 2026.

Healthcare AI gains a concrete test

The case study involved a large U.S. integrated health system using Teradata technology for digital care programs. The programs drew on nearly 150 patient features and served a health system with more than one million patients, while the reported engagement increase reached 520 percent.

A separate European research institution used a 2-million-parameter model to predict disease onset up to 10 years ahead. The model reached 70 percent accuracy, and Teradata said its in-database deployment became operational within three days, according to FT.

Q2 revenue beat supports the story

The latest reported quarter provides the financial counterweight to the product examples. Teradata generated USD 410 million of Q2 2026 revenue against USD 396.13 million consensus and reported adjusted earnings per share of USD 0.69 versus USD 0.56 expected, according to MarketBeat on October 3, 2026.

Teradata's Q3 2026 adjusted EPS guidance was USD 0.55-0.59, while full-year adjusted EPS guidance stood at USD 2.65-2.73. The company also reported Q2 recurring revenue growth of 3 percent and adjusted EBITDA of 27.1 percent on its investor-relations page, covering the quarter ended June 30, 2026, according to Teradata.

Consensus target stays above the stock

Analyst coverage remains measured. The consensus rating is Hold from eight analysts, with an average target of USD 33.50, according to MarketScreener on September 22, 2026. That target lies 14.9 percent above the October 7 price, while UBS had cut its target from USD 36 to USD 32 and retained a Neutral rating on September 21, 2026.

For investors, the contrast is clear: Teradata's latest customer examples quantify potential AI use cases, while the 3 percent recurring-revenue growth figure shows that commercial acceleration remains the financial checkpoint.

Teradata stock remains below analyst target

Teradata stock was last at USD 29.16 on the NYSE on October 7, 2026 at 4:00 p.m. ET. Its market capitalization was USD 2.7 billion, and its 52-week range was USD 20.33-41.78.